<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04640155</url>
  </required_header>
  <id_info>
    <org_study_id>STU00213194</org_study_id>
    <nct_id>NCT04640155</nct_id>
  </id_info>
  <brief_title>Treating Chronic Pouchitis With a Low FODMAP Diet</brief_title>
  <official_title>Treating Chronic Pouchitis With a Low FODMAP Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to determine whether low FODMAP diet in patients with chronic pouchitis will improve&#xD;
      symptoms and pouch inflammation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following recruitment for entry into the study, subjects be asked to complete symptom surveys&#xD;
      and provide a fecal sample for calprotectin measurement. Shortly after their screening visit,&#xD;
      patients will be randomized 1:1 to either the low FODMAP diet (experimental) or regular diet&#xD;
      (control) group. Patients in the experimental group will schedule a telephone visit with a&#xD;
      registered dietician. During this approximately hour-long session, patients in the low FODMAP&#xD;
      cohort will be counseled regarding FODMAP containing foods. They will be asked to adhere to&#xD;
      this diet over the next 6 weeks. At the end of the 6 week period, subjects will complete a&#xD;
      3-day food diary. Those in the regular diet group will be contacted by the dietician and&#xD;
      given an educational handout at the beginning of the study period regarding best dietary&#xD;
      practices. At the end of the 6 week study period, both groups will again be asked to complete&#xD;
      another set of symptom surveys and provide a fecal sample for calprotectin measurement.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 27, 2020</start_date>
  <completion_date type="Anticipated">October 27, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 27, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Difference in Fecal Calprotectin</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Difference in Composite Symptom Scores</measure>
    <time_frame>6 weeks</time_frame>
    <description>Composite symptom score will include both clinical portion of Pouchitis Disease Activity Index as well as Oresland score, with possible scores ranging from 0-21 (higher number indicates higher symptom burden)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Difference in Cleveland Global Quality of Life Score</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Normalization of Fecal Calprotectin</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pouchitis</condition>
  <arm_group>
    <arm_group_label>Regular Diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low FODMAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low FODMAP Diet</intervention_name>
    <description>Patients in the low FODMAP group will schedule a telephone visit with a registered dietician. During this approximately hour-long session, patients in the low FODMAP cohort will be counselled regarding FODMAP containing foods and how to effectively remove them while maintaining a nutrition-rich diet.</description>
    <arm_group_label>Low FODMAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Regular Diet</intervention_name>
    <description>Patients in the regular diet group will receive an educational handout discussing low fiber diet, which is standard of care for those with pouchitis symptoms.</description>
    <arm_group_label>Regular Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Patients aged 18-65 with a diagnosis of ulcerative colitis that have undergone ileal&#xD;
             pouch-anal anastomosis following proctocolectomy for medication-refractory disease&#xD;
&#xD;
          -  Either â‰¥4 episodes of pouchitis per year (antibiotic-dependent) OR persistent symptoms&#xD;
             despite 4 weeks of antibiotic therapy (antibiotic-resistant)&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Diagnosis of indeterminate colitis or Crohn's disease&#xD;
&#xD;
          -  Celiac disease&#xD;
&#xD;
          -  Current use of low FODMAP diet&#xD;
&#xD;
          -  Known dietary allergies&#xD;
&#xD;
          -  Current use of antibiotics for reasons other than treatment of pouchitis&#xD;
&#xD;
          -  Clostridium difficile infection&#xD;
&#xD;
          -  Complication following ileal pouch-anal anastomosis requiring reoperation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen B Hanauer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University Feinberg School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adam C Niemann, MD</last_name>
    <phone>2172576982</phone>
    <email>adam.niemannn@northwestern.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Northwestern Medicine Digestive Health Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam C Niemann, MD</last_name>
      <phone>217-257-6982</phone>
      <email>adam.niemann@northwestern.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 17, 2020</study_first_submitted>
  <study_first_submitted_qc>November 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2020</study_first_posted>
  <last_update_submitted>November 23, 2020</last_update_submitted>
  <last_update_submitted_qc>November 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Stephen Hanauer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Low FODMAP Diet</keyword>
  <keyword>Pouchitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pouchitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

